
We're proud to share that Map My Mole has been awarded the Barclays Entrepreneur Award for Innovation in Health and Life Sciences.
We’re thrilled to share the judges’ feedback from the Barclays Entrepreneur Awards:
"This year's winner impressed the judges with their truly innovative approach to a major healthcare challenge. Their technology is not only accessible and user-friendly, but it’s also making a measurable impact by reducing NHS referrals and GP appointments - helping to ease the pressure on frontline services.
The judges praised the company’s unique business model, which brings together pharmacists, aestheticians, and other ecosystem partners in an inclusive and collaborative way. They demonstrate strong ethical foundations and a sound financial model and are a great example of what’s possible when innovation meets purpose."
This award goes to all of our amazing partners - GPs, pharmacists, aestheticians, and patients - who are making early skin cancer detection faster, fairer, and more accessible.
Why It Matters
Skin cancer referrals are rising. GP appointments are under pressure. NHS waiting lists are long. And yet – early detection saves lives.
Map My Mole is revolutionising the pathway:
We’re proving that innovation in healthcare doesn't mean more complexity. It means real impact at scale, with tools that are human-centred, fast, and scalable.
A Model for the Future of Healthcare
From pharmacy counters to digital capture hubs, Map My Mole is building a UK-wide network of accessible skin health services. Our partners now span:
With a simple dermatoscope and an app, our partners are bringing consultant dermatology expertise to every high street. This is preventive medicine in action – not just treating disease but catching it before it spreads.
“I was impressed not only by their cutting-edge technologies and truly innovative processes, but also by their passion and drive to make real, measurable impacts to people’s lives and health. I cannot wait to see what they do next!” - Noriane Simon, Ph.D. Head of Enterprise and Ventures | Bioscience & Biotech, BBSRC and Barclays Award Judge
Gratitude & Looking Ahead
This award belongs to our entire ecosystem – from the 1000+ partners, to the patients who trusted us with their care.
We’re especially grateful to the judges, Barclays, and the community of innovators we celebrated with on the night, including Chris Owen Smith, our impeccably dressed co-founder representing us in style!
------------------------------------
Join Us
Download the Map My Mole App
Apply to become a service provider
Help us put early detection on every high street
About Map My Mole
Map My Mole is a UK-based digital dermatology platform offering fast, consultant-reviewed skin assessments through smartphone-enabled mole checks. Its mission is to make early skin cancer detection accessible, affordable, and impactful.
Media Contact
Sophie Bailey